Abrams WB - Search Results

1

Debrisoquin, a selective inhibitor of intraneuronal monoamine oxidase in man.

Pettinger WA, Korn A, Spiegel H, Solomon HM, Pocelinko R, Abrams WB. Pettinger WA, et al. Among authors: abrams wb. Clin Pharmacol Ther. 1969 Sep-Oct;10(5):667-74. doi: 10.1002/cpt1969105667. Clin Pharmacol Ther. 1969. PMID: 5808462 No abstract available.

2

The human platelet as a pharmacologic model for the adrenergic neuron. The uptake and release of norepinephrine.

Abrams WB, Solomon HM. Abrams WB, et al. Clin Pharmacol Ther. 1969 Sep-Oct;10(5):702-9. doi: 10.1002/cpt1969105702. Clin Pharmacol Ther. 1969. PMID: 4390109 No abstract available.

3

The accumulation and metabolism of dopamine by the human platelet.

Solomon HM, Spirt NM, Abrams WB. Solomon HM, et al. Among authors: abrams wb. Clin Pharmacol Ther. 1970 Nov-Dec;11(6):838-45. doi: 10.1002/cpt1970116838. Clin Pharmacol Ther. 1970. PMID: 4394753 No abstract available.

4

The influence of debrisoquin on the accumulation and metabolism of biogenic amines by the human platelet, in vivo and in vitro.

Solomon HM, Ashley C, Spirt N, Abrams WB. Solomon HM, et al. Among authors: abrams wb. Clin Pharmacol Ther. 1969 Mar-Apr;10(2):229-38. doi: 10.1002/cpt1969102229. Clin Pharmacol Ther. 1969. PMID: 5775990 No abstract available.

5

Interactions between digitoxin and other drugs in man.

Solomon HM, Abrams WB. Solomon HM, et al. Among authors: abrams wb. Am Heart J. 1972 Feb;83(2):277-80. doi: 10.1016/0002-8703(72)90148-2. Am Heart J. 1972. PMID: 5058316 No abstract available.

6

Effects of anorexiants on plasma lipids and other physiological parameters in man.

Gaut ZN, Pocelinko R, Abrams WB, Dalton C. Gaut ZN, et al. Among authors: abrams wb. J Clin Pharmacol J New Drugs. 1969 Sep-Oct;9(5):315-20. J Clin Pharmacol J New Drugs. 1969. PMID: 4899112 Clinical Trial. No abstract available.

7

CLINICAL PHARMACOLOGICAL STUDIES WITH DEBRISOQUIN SULFATE, A NEW ANTIHYPERTENSIVE AGENT.

ABRAMS WB, POCELINKO R, KLAUSNER M, HANAUER L, WHITMAN EN. ABRAMS WB, et al. J New Drugs. 1964 Sep-Oct;4(5):268-83. doi: 10.1002/j.1552-4604.1964.tb00372.x. J New Drugs. 1964. PMID: 14218621 No abstract available.

8

Pyridoxine antagonism of levodopa in parkinsonism.

Leon AS, Spiegel HE, Thomas G, Abrams WB. Leon AS, et al. Among authors: abrams wb. JAMA. 1971 Dec 27;218(13):1924-7. JAMA. 1971. PMID: 5171069 No abstract available.

9

Interactions between digitoxin and other drugs in vitro and in vivo.

Solomon HM, Reich S, Spirt N, Abrams WB. Solomon HM, et al. Among authors: abrams wb. Ann N Y Acad Sci. 1971 Jul 6;179:362-9. doi: 10.1111/j.1749-6632.1971.tb46913.x. Ann N Y Acad Sci. 1971. PMID: 5285381 No abstract available.

10

THE CLINICAL PHARMACOLOGY OF POSTGANGLIONIC SYMPATHETIC BLOCKING AGENTS.

ABRAMS WB, POCELINKO R, MOE RA, BATES H, HANAUER L, CAMACHO S. ABRAMS WB, et al. Dis Chest. 1965 Aug;48:178-86. Dis Chest. 1965. PMID: 14333651 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters